Cargando…
Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing
OBJECTIVES: Tumor biomarker analyses accompanying immuno-oncology therapies are coupled with a tumor tissue journey aiming to guide tissue procurement and allow for accurate diagnosis and delivery of test results. The engagement of pathologists in the tumor tissue journey is essential because they a...
Autores principales: | De Las Casas, Luis E, Hicks, David G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130880/ https://www.ncbi.nlm.nih.gov/pubmed/33582767 http://dx.doi.org/10.1093/ajcp/aqaa212 |
Ejemplares similares
-
Review by urological pathologists improves the accuracy of Gleason grading by general pathologists
por: Nakai, Yasushi, et al.
Publicado: (2015) -
A journey to the edge of understanding
Publicado: (2008) -
Tissue management in precision medicine: What the pathologist needs to know in the molecular era
por: Souza da Silva, Ricella, et al.
Publicado: (2022) -
Two-step artificial intelligence system for endoscopic gastric biopsy improves the diagnostic accuracy of pathologists
por: Zhu, Yan, et al.
Publicado: (2022) -
Molecular Testing in Ovarian Tumours: Challenges from the Pathologist’s Perspective
por: Dinneen, Kate, et al.
Publicado: (2023)